We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

© 2019 Technology Networks, all rights reserved

The Enduring Success of Hybridoma-based Antibody Development

White Paper   Aug 14, 2019

Since its original development in 1975, hybridoma technology encourages researchers all over the world to share their antibodies with one another, unlocking a vast amount of potential for biological research.

Due to their high selectivity, monoclonal antibodies (mAbs) are used in a wide range of disciplines, including research, diagnostics and therapeutic applications. Despite the advancement of modern antibody generation technologies, hybridoma-based antibody production continues to be a leading approach for mAb discovery and development.

Download these whitepapers to explore:

  • The key benefits of using hybridoma-based antibody development
  • Perceived misconceptions relating to hybridoma technology
  • Alternative approaches that currently exist for mAb generation
VIEW WHITEPAPER

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

Related White Papers

Generate Rabbit Antibodies of Superior Target Precision and Affinity with MonoRab™

White Paper

Download this white paper to find out how rabbit mAbs can be reliably generated with the upgraded MonoRab™ platform.

READ MORE

Advanced Host Cell Protein (HCP) Analysis with TIMS QTOF MS Powers Biopharmaceutical Development

White Paper

Download this whitepaper to find out how you can advance your host cell protein analysis.

READ MORE

Best Practices for Cell Culture Confluency Calculation With InCellis®

White Paper

Download this whitepaper to find out how InCellis® can enhance your confluency measurements.

READ MORE

Related Content